Medina-Mora IME, del Campo SRM, Villatoro VJA

Language: English
References: 11
Page: 157-158
PDF size: 141.78 Kb.

Text Extraction

In April 2016, at the 30th Special Session of the United Nations General Assembly, heads of state and government, together with ministers and representatives of the member states, convened to review progress in the implementation of the “Political Declaration and Plan of Action on International Cooperation in Favor of a Comprehensive and Balanced Strategy to Counter the World Drug Problem” (Oficina de las Naciones Unidas Contra la Droga y el Delito [UNODC], 2016).
At that occasion, member states recognized that while tangible progress had been made in some areas, the world drug problem continued to pose challenges to the health, safety, and welfare of all humanity, and that the high cost of the drug problem reaffirmed the need for comprehensive, balanced, sustainable, and viable policy interventions to promote the livelihoods of the world’s people. Today, five years after the UNGASS declaration, we evaluated its impact.

REFERENCES

1. Buxton, J., Margo, G., & Burger, L. (Eds.). (2021). The Impact of Global Drug Policy on Women: Shifting the Needle. Emerald Publishing.

2. Chimbar, L., & Moleta, Y. (2018). Naloxone effectiveness: a systematic review. Journal of Addictions Nursing, 29(3), 167-171. doi: 10.1097/JAN.0000000000000230

3. Fleiz, C., Arredondo, J., Chavez, A., Pacheco, L., Segovia, L. A., Villatoro, J. A., ... de la Fuente, J. R. (2020). Fentanyl is used in Mexico's northern border: current challenges for drug health policies. Addiction, 115(4), 778-781. doi: 10.1111/ add.14934

4. Harm Reduction International. (2020). Global State of Harm Reduction 2020. London: Harm Reduction International.

5. Junta Internacional de Fiscalización de Estupefacientes [JIFE]. (2019). Progresos en lo que respecta a garantizar el acceso adecuado a sustancias sujetas a fiscalización internacional para fines médicos y científicos. Viena: Naciones Unidas. Retrieved from https://www.incb.org/documents/Publications/ AnnualReports/AR2018/Supplement/Supplement_S_ebook.pdf

6. Medina-Mora, M. E. (2020). COVID-19 and mental health: Challenges and opportunities. Salud Mental, 43(6), 241-242. doi: 10.17711/sm.0185-3325.2020.033

7. Nougier, M., Cots-Fernández, A., & Putri, D. (2021). Taking stock of half a decade of drug policy - an evaluation of UNGASS implementation. London: International Drug Policy Consortium. Retrieved from https://www.drugsandalcohol.ie/34042/

8. Oficina de las Naciones Unidas Contra la Droga y el Delito [UNODC]. (2016). Documento final del período extraordinario de sesiones de la Asamblea General de las Naciones Unidas sobre el problema mundial de las drogas celebrado en 2016. Nueva York: Naciones Unidas. Retrieved from https://www.unodc.org/ documents/postungass2016/outcome/V1603304-S.pdf

9. Secretaría de Salud. (2019). Informe sobre la situación del consumo de drogas en México y su atención integral. Ciudad de México. Retrieved from https://www. gob.mx/cms/uploads/attachment/file/477564/Informe_sobre_la_situacio_n_ de_las_drogas_en_Me_xico_.pdf

10. Valenzuela-Lara, M., Ponce-Ramos, M., Ruiz-Herrera, K., & López-González, A. (2019). Impact of funding harm reduction programs for people who inject drugs in Mexico. Salud Mental, 42(4), 157-163. doi: 10.17711/SM.0185- 3325.2019.021

11. Volkow, N. D., Poznyak, V., Saxena, S., Gerra, G., & UNODC-WHO Informal International Scientific Network. (2017). Drug use disorders: impact of a public health rather than a criminal justice approach. World Psychiatry, 16(2), 213- 214. doi: 10.1002/wps.20428